Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)287.92
  • Today's Change1.57 / 0.55%
  • Shares traded638.67k
  • 1 Year change+1.02%
  • Beta0.4607
Data delayed at least 20 minutes, as of Mar 28 2024 05:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, CSL Ltd (CSL:ASX) closed at 287.92, -8.01% below its 52-week high of 312.99, set on Jun 06, 2023.
52-week range
Today
228.65Oct 30 2023312.99Jun 06 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open287.99
High289.76
Low286.98
Bid286.40
Offer288.00
Previous close286.35
Average volume802.58k
Shares outstanding483.25m
Free float480.99m
P/E (TTM)36.65
Market cap138.38bn AUD
EPS (TTM)7.81
AUD
Annual div (ADY)3.89
AUD
Annual div yield (ADY)1.36%
Div ex-dateMar 11 2024
Div pay-dateApr 03 2024
Data delayed at least 20 minutes, as of Mar 28 2024 05:10 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.